Recent advances in immunotherapy for gliomas: overcoming barriers and advancing precision strategies
Gliomas, and particularly glioblastoma (GBM), remain among the most lethal primary brain tumors, with outcomes constrained by extensive intra tumor heterogeneity, a profoundly immunosuppressive tumor microenvironment (TME), and the restrictive nature of the blood–brain barrier (BBB). Although immuno...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2026-01-01
|
| Reeks: | Frontiers in Immunology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1690464/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|